1,3-dipropyl-8-cyclopentylxanthine has been researched along with Tachyarrhythmia in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lou, Q | 1 |
| Hansen, BJ | 1 |
| Fedorenko, O | 1 |
| Csepe, TA | 1 |
| Kalyanasundaram, A | 1 |
| Li, N | 1 |
| Hage, LT | 1 |
| Glukhov, AV | 1 |
| Billman, GE | 1 |
| Weiss, R | 1 |
| Mohler, PJ | 1 |
| Györke, S | 1 |
| Biesiadecki, BJ | 1 |
| Carnes, CA | 1 |
| Fedorov, VV | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Tachyarrhythmia
| Article | Year |
|---|---|
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Brady | 2014 |